| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 1723-1734, Copyright © 1994 by Endocrine Society
ARTICLES |
J Zhou, BA Dsupin, LC Giudice and CA Bondy
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
To study the cellular patterns of gene expression of the insulin-like growth factor (IGF) system in human endometrium during the menstrual cycle, we used in situ hybridization histochemistry to localize messenger ribonucleic acids (mRNAs) encoding IGF-I and -II, their receptors, and their binding proteins (IGFBPs) in fresh-frozen endometrial tissue obtained from cycling women. IGF-I and IGF-II mRNAs are both expressed diffusely throughout endometrial stroma and are not detected in endometrial epithelium. Endometrial IGF-I mRNA is significantly more abundant during the proliferative than the secretory phase of the menstrual cycle, whereas the reverse is true for IGF-II. Type I and type II IGF receptor mRNAs are both present in endometrial stroma, but are relatively more abundant in endometrial epithelium, and neither shows distinctive cyclic changes. IGFBP-2, -4, -5, and -6 mRNAs demonstrate a diffuse stromal pattern of expression, whereas IGFBP-1 and -3 are more focally concentrated in selected subpopulations of endometrial cells. IGFBP-1 mRNA is not detected in proliferative endometrium and demonstrates a very heterogeneous pattern of expression in secretory endometrium, where it is intensely abundant in a patchy distribution of stromal and epithelial cells. IGFBP-3 mRNA is primarily concentrated in endometrial capillaries and is increased in the secretory phase, largely due to the intense vascularization of endometrial glands during this phase. IGFBP-5 mRNA is more abundant in the proliferative phase, but all other IGFBP mRNAs are relatively increased in the secretory phase of the menstrual cycle. These findings support the view that the IGF system plays a fundamental role in endometrial biology, acting via autocrine and/or paracrine mechanisms, with IGF-I and IGFBP-5 being dominant in the proliferative phase, and IGF-II and the other IGFBPs predominant in the secretory phase of the menstrual cycle.
This article has been cited by other articles:
 |
|
 |
|
  H. Matsumoto, K. Sakai, and M. Iwashita Insulin-like growth factor binding protein-1 induces decidualization of human endometrial stromal cells via {alpha}5{beta}1 integrin Mol. Hum. Reprod., August 1, 2008; 14(8): 485 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kim, G. Song, H. Gao, J. L. Farmer, M. C. Satterfield, R. C. Burghardt, G. Wu, G. A. Johnson, T. E. Spencer, and F. W. Bazer Insulin-Like Growth Factor II Activates Phosphatidylinositol 3-Kinase-Protooncogenic Protein Kinase 1 and Mitogen-Activated Protein Kinase Cell Signaling Pathways, and Stimulates Migration of Ovine Trophectoderm Cells Endocrinology, June 1, 2008; 149(6): 3085 - 3094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, J. E. Manson, J. Li, T. G. Harris, T. E. Rohan, X. Xue, G. Y.F. Ho, et al. A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang and D. Yee Is the type I insulin-like growth factor receptor a therapeutic target in endometrial cancer? Clin. Cancer Res., November 1, 2006; 12(21): 6323 - 6325. [Full Text] [PDF]
|
|
|
|
 |
|
 W.-P. Hu, S. K. Tay, and Y. Zhao Endometriosis-Specific Genes Identified by Real-Time Reverse Transcription-Polymerase Chain Reaction Expression Profiling of Endometriosis Versus Autologous Uterine Endometrium J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 228 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.A. White, E. Dimitriadis, A.M. Sharkey, and L.A. Salamonsen Interleukin-11 inhibits expression of insulin-like growth factor binding protein-5 mRNA in decidualizing human endometrial stromal cells Mol. Hum. Reprod., September 1, 2005; 11(9): 649 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C.J.P. Gielen, E. E. Hanekamp, L. J. Blok, F. J. Huikeshoven, and C. W. Burger Steroid-Modulated Proliferation of Human Endometrial Carcinoma Cell Lines: Any Role for Insulin-like Growth Factor Signaling? Reproductive Sciences, January 1, 2005; 12(1): 58 - 64. [Abstract] [PDF]
|
|
|
|
|
|
J. V. Lacey Jr., N. Potischman, M. P. Madigan, M. L. Berman, R. Mortel, L. B. Twiggs, R. J. Barrett, G. D. Wilbanks, J. R. Lurain, C.-M. Fillmore, et al. Insulin-Like Growth Factors, Insulin-Like Growth Factor-Binding Proteins, and Endometrial Cancer in Postmenopausal Women: Results from a U.S. Case-Control Study Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Philippoussis, D. Gagne, P. Hugo, and D. Gosselin Concentrations of Alpha-Fetoprotein, Insulin-Like Growth Factor Binding Protein-3, c-erbB-2, and Epidermal Growth Factor in Serum of Patients With Endometriosis Reproductive Sciences, April 1, 2004; 11(3): 175 - 181. [Abstract] [PDF]
|
|
|
|
 |
|
 E. P. Tierney, S. Tulac, S.-T. J. Huang, and L. C. Giudice Activation of the protein kinase A pathway in human endometrial stromal cells reveals sequential categorical gene regulation Physiol Genomics, December 16, 2003; 16(1): 47 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Riesewijk, J. Martin, R. van Os, J. A. Horcajadas, J. Polman, A. Pellicer, S. Mosselman, and C. Simon Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology Mol. Hum. Reprod., May 1, 2003; 9(5): 253 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kaaks, A. Lukanova, and M. S. Kurzer Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1531 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Makrigiannakis, G. Coukos, A. Mantani, P. Prokopakis, G. Trew, R. Margara, R. Winston, and J. White Expression of Wilms' Tumor Suppressor Gene (WT1) in Human Endometrium: Regulation through Decidual Differentiation J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5964 - 5972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bajoria, M. J. Gibson, S. Ward, S. R. Sooranna, J. P. Neilson, and M. Westwood Placental Regulation of Insulin-Like Growth Factor Axis in Monochorionic Twins with Chronic Twin-Twin Transfusion Syndrome J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3150 - 3156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dhara, P.G.L. Lalitkumar, J. Sengupta, and D. Ghosh Immunohistochemical localization of insulin-like growth factors I and II at the primary implantation site in the Rhesus monkey Mol. Hum. Reprod., April 1, 2001; 7(4): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pierro, F. Minici, O. Alesiani, F. Miceli, C. Proto, I. Screpanti, S. Mancuso, and A. Lanzone Stromal-Epithelial Interactions Modulate Estrogen Responsiveness in Normal Human Endometrium Biol Reprod, March 1, 2001; 64(3): 831 - 838. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Degeorges, F. Wang, H. F. Frierson , Jr., A. Seth, and R. A. Sikes Distribution of IGFBP-rP1 in Normal Human Tissues J. Histochem. Cytochem., June 1, 2000; 48(6): 747 - 754. [Abstract] [Full Text]
|
|
|
|
|
|
T.S. Gadd, J.C. Osgerby, and D.C. Wathes Regulation and Localization of Insulin-Like Growth Factor Binding Protein-5 Gene Expression in the Uterus and Placenta of the Cyclic and Early Pregnant Ewe Biol Reprod, May 1, 2000; 62(5): 1415 - 1421. [Abstract] [Full Text]
|
|
|
|
 |
|
 H.-S. Wang, T.-H. Wang, and Y.-K. Soong Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy Hum. Reprod., January 1, 2000; 15(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fowler, G. Albaiges, C. Lees, J. Jones, K. Nicolaides, and J. Miell The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by Doppler ultrasound Hum. Reprod., November 1, 1999; 14(11): 2881 - 2885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. O. Adesanya, J. Zhou, C. Samathanam, L. Powell-Braxton, and C. A. Bondy Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle PNAS, March 16, 1999; 96(6): 3287 - 3291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L. Keller, A.J. Roberts, and G.E. Seidel Jr. Characterization of Insulin-Like Growth Factor-Binding Proteins in the Uterus and Conceptus during Early Conceptus Elongation in Cattle Biol Reprod, July 1, 1998; 59(3): 632 - 642. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Graham and C. L. Clarke Physiological Action of Progesterone in Target Tissues Endocr. Rev., August 1, 1997; 18(4): 502 - 519. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
